Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xaj1
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 133M | $225M | 100% | Mar 2026 |
|
| D. E. Shaw & Co | 63M | $107M | 100% | Mar 2026 |
|
| Franklin Resources | 59M | $100M | 100% | Mar 2026 |
|
| OZ Management | 40M | $68M | 100% | Mar 2026 |
|
| Invesco | 29M | $50M | 100% | Mar 2026 |
|
| BlackRock | 24M | $40M | 100% | Mar 2026 |
|
| Nuveen | 21M | $35M | 100% | Mar 2026 |
|
| Jump Financial | 18M | $31M | 100% | Mar 2026 |
|
| CSS | 10M | $17M | 100% | Mar 2026 |
|
| Alberta Investment Management Corporation | 10M | $17M | 100% | Mar 2026 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 10M | $17M | 100% | Mar 2026 |
|
| Wellington Management Company | 8.1M | $14M | 100% | Mar 2026 |
|
| Calamos Advisors | 8.1M | $14M | 100% | Mar 2026 |
|
| Susquehanna Advisors Group | 7.5M | $128k | 100% | Mar 2026 |
|
| State Street Corporation | 7.2M | $12M | 100% | Mar 2026 |
|
| FMR | 6.6M | $11M | 100% | Mar 2026 |
|
| Gabelli Funds | 6.1M | $10M | 100% | Mar 2026 |
|
| Nicholas Investments Partners | 6.0M | $10M | 100% | Mar 2026 |
|
| Ameriprise Financial | 6.0M | $10M | 100% | Mar 2026 |
|
| Wolverine Asset Management | 5.6M | $9.6M | 100% | Mar 2026 |
|
| SSI Investment Management | 4.1M | $7.0M | 100% | Mar 2026 |
|
| Bank of America Corporation | 3.5M | $6.0M | 100% | Mar 2026 |
|
| State of Wisconsin Investment Board | 3.0M | $5.1M | 100% | Mar 2026 |
|
| Goldman Sachs Group | 2.7M | $4.7M | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.7M | $2.8M | 100% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 1.4M | $2.4M | 100% | Mar 2026 |
|
| 683 Capital Management | 1.0M | $1.7M | 100% | Mar 2026 |
|
| Lazard Asset Management | 843k | $14k | 100% | Mar 2026 |
|
| Jane Street | 700k | $1.2M | 100% | Mar 2026 |
|
| Wells Fargo & Company | 677k | $1.2M | 100% | Mar 2026 |
|
| Millennium Management | 500k | $849k | 100% | Mar 2026 |
|
| Ares Systematic Credit | 300k | $486k | 100% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 298k | $505k | 100% | Mar 2026 |
|
| Diadema Partners | 250k | $19M | 100% | Mar 2026 |
|
| Central Pacific Bank - Trust Division | 236k | $397k | 100% | Jun 2026 |
|
| Man Group | 225k | $382k | 100% | Mar 2026 |
|
| Bank of New York Mellon | 200k | $340k | 100% | Mar 2026 |
|
| Wellesley Investment Advisors | 125k | $213M | 100% | Mar 2026 |
|
| Persistent Asset Partners | 60k | $102k | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 30k | $4.9M | 100% | Mar 2026 |
|